A clinical-study record marked completed can sound like a successful treatment story. The label describes a stage in the study’s conduct; the findings require a separate reading.
In its protocol data definitions, ClinicalTrials.gov describes completed studies as having concluded normally, with participants no longer receiving the intervention or being examined. That definition does not say the experimental treatment produced a benefit.
Consider a fictional trial that finishes all planned visits. Its analysis might support a benefit, reveal harms, find an uncertain difference or answer the question in another way. The same completed status cannot distinguish those possibilities.
Read the record in separate layers
First identify the study and its current status. Then look for posted results, linked publications and the outcomes actually reported. Keep the date you checked, because a registry record and a journal article may be updated on different schedules.
Do not treat the absence of posted results as proof that a treatment failed, or a completed status as proof that it worked. Both shortcuts replace missing evidence with a conclusion.
A useful public summary might state that study visits have ended while the result remains unavailable in the sources consulted. If results are available, describe them with their comparison, uncertainty and limitations.
This is a reading aid, not guidance to start or stop treatment. Decisions about care require appropriate clinical advice and the relevant evidence, not a registry status badge.
Editorial illustration from the site’s image collection.